401
|
Luo X, Yu RC, Wang XJ, Zhou MJ. Toxin composition and toxicity dynamics of marine gastropod Nassarius spp. collected from Lianyungang, China. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2011; 29:117-27. [PMID: 22029636 DOI: 10.1080/19440049.2011.615069] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
Abstract
Consumption of nassariid gastropods often leads to poisoning incidents in some coastal provinces in China. To elucidate the pattern of toxicity dynamics and origin of toxins, samples of gastropod Nassarius spp. were collected from late May to early August 2007 from Lianyungang, Jiangsu province, where the poisoning incidents have been frequently reported. Toxicity was first screened with the mouse bioassay method, and tetrodotoxin and its analogues (TTXs) were analysed with high-performance liquid chromatography coupled with an ion-trap mass spectrometer (HPLC-MS(n)). The toxicity of nassariid N. semiplicatus showed an 'M'-shaped pattern of fluctuation during the sampling season. Two peaks of toxicity appeared in late May and late July. The maximum toxicity was recorded on 24 May, with the value of 846 mouse unit (MU) g(-1) of tissue (wet weight). TTX and its analogues trideoxyTTX, 4-epiTTX, anhydroTTX and oxoTTX were detected in the nassariid samples. TrideoxyTTX but not TTX was the major toxin in all the samples. No paralytic shellfish poison (PSP) was detected in the sample with the maximum toxicity by HPLC-FLD analysis. Variation of TTX content in the tissue of nassariid gastropods correlates well with the dynamics of toxicity. It is suggested that TTXs are the major toxins corresponding to the toxicity of the nassariids, and May and July are the high-risk seasons for consumption of nassariids, which is critical for the management of poisoning incidents.
Collapse
|
402
|
Moriera F, So K, Gould P, Kamnasaran D, Jensen RL, Hussain I, Gutmann DH, Gorovets D, Kastenhuber ER, Pentsova E, Nayak L, Huse JT, van den Bent MJ, Gravendeel LA, Gorlia T, Kros JM, Wesseling P, Teepen J, Idbaih A, Sanson M, Smitt PAS, French PJ, Zhang W, Zhang J, Hoadley K, Carter B, Li S, Kang C, You Y, Jiang C, Song S, Jiang T, Chen C, Grimm C, Weiler M, Claus R, Weichenhan D, Hartmann C, Plass C, Weller M, Wick W, Jenkins RB, Sicotte H, Xiao Y, Fridley BL, Decker PA, Kosel ML, Kollmeyer TM, Fink SR, Rynearson AL, Rice T, McCoy LS, Smirnov I, Tehan T, Hansen HM, Patoka JS, Prados MD, Chang SM, Berger MS, Lachance DH, Wiencke JK, Wiemels JL, Wrensch MR, Gephart MH, Lee E, Kyriazopoulou-Panagiotopoulou S, Milenkovic L, Xun X, Hou Y, Kui W, Edwards M, Batzoglou S, Jun W, Scott M, Hobbs JE, Tipton J, Zhou T, Kelleher NL, Chandler JP, Schwarzenberg J, Czernin J, Cloughesy T, Ellingson B, Geist C, Phelps M, Chen W, Nakada M, Hayashi Y, Obuchi W, Ohtsuki S, Watanabe T, Ikeda C, Misaki K, Kita D, Hayashi Y, Uchiyama N, Terasaki T, Hamada JI, Hiddingh L, Tops B, Hulleman E, Kaspers GJL, Vandertop WP, Wesseling P, Noske DP, Wurdinger T, Jeuken JW, See AP, Hwang T, Shin D, Shin JH, Gao Y, Lim M, Hutterer M, Michael M, Gerold U, Karin S, Ingrid G, Florian D, Armin M, Eugen T, Eberhard G, Gunther S, Cook RW, Oelschlager K, Sevim H, Chung L, Wheeler HT, Baxter RC, McDonald KL, Chaturbedi A, Yu L, Zhou YH, Chaturbedi A, Wong A, Fatuyi R, Linskey ME, Zhou YH, Lavon I, Shahar T, Zrihan D, Granit A, Ram Z, Siegal T, Brat DJ, Cooper LA, Gutman DA, Chisolm CS, Appin C, Kong J, Kurc T, Van Meir EG, Saltz JH, Moreno CS, Abuhusain HJ, McDonald KL, Don AS, Nagarajan RP, Johnson BE, Olshen AB, Smirnov I, Xie M, Wang J, Sundaram V, Paris P, Wang T, Costello JF, Sijben AE, Boots-Sprenger SH, Boogaarts J, Rijntjes J, Geitenbeek JM, van der Palen J, Bernsen HJ, Wesseling P, Jeuken JW, Schnell O, Adam SA, Eigenbrod S, Kretzschmar HA, Tonn JC, Schuller U, Schwarzenberg J, Cloughesy T, Czernin J, Geist C, Phelps M, Chen W, Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta MP, Kwatra MM, Porter TM, Brown KE, Herndon JE, Bigner DD, Dahlrot RH, Kristensen BW, Hansen S, Sulman EP, Cahill DP, Wang M, Won M, Hegi ME, Mehta MP, Aldape KD, Gilbert MR, Sadr ES, Tessier A, Sadr MS, Alshami J, Sabau C, Del Maestro R, Neal ML, Rockne R, Trister AD, Swanson KR, Maleki S, Back M, Buckland M, Brazier D, McDonald K, Cook R, Parker N, Wheeler H, Jalbert L, Elkhaled A, Phillips JJ, Yoshihara HA, Parvataneni R, Srinivasan R, Bourne G, Chang SM, Cha S, Nelson SJ, Aldape KD, Gilbert M, Cahill D, Wang M, Won M, Hegi M, Colman H, Mehta M, Sulman E, Elkhaled A, Jalbert L, Constantin A, Phillips J, Yoshihara H, Srinivasan R, Bourne G, Chang SM, Cha S, Nelson S, Gunn S, Reveles XT, Tirtorahardjo B, Strecker MN, Fichtel L. -OMICS AND PROGNOSTIC MARKERS. Neuro Oncol 2011. [DOI: 10.1093/neuonc/nor167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
403
|
Day C, Haas H, Hanke S, Hauer V, Luo X, Scannapiego M, Simon R, Strobel H, Fellin F, Lässer R, Masiello A, Papastergiou S, Dremel M, Mayaux C, Pearce R. Design progress for the ITER torus and neutral beam cryopumps. FUSION ENGINEERING AND DESIGN 2011. [DOI: 10.1016/j.fusengdes.2010.11.023] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
404
|
Luo X, Yang Y, Li Z. Preliminary study on ventricular arterial coupling of patients with hypertension by ultrasonography. BRITISH HEART JOURNAL 2011. [DOI: 10.1136/heartjnl-2011-300867.564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
405
|
Gibly RF, Graham JG, Luo X, Lowe WL, Hering BJ, Shea LD. Advancing islet transplantation: from engraftment to the immune response. Diabetologia 2011; 54:2494-505. [PMID: 21830149 PMCID: PMC3193607 DOI: 10.1007/s00125-011-2243-0] [Citation(s) in RCA: 100] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/18/2011] [Accepted: 06/21/2011] [Indexed: 12/11/2022]
Abstract
The promise and progress of islet transplantation for treating type 1 diabetes has been challenged by obstacles to patient accessibility and long-term graft function that may be overcome by integrating emerging technologies in biomaterials, drug delivery and immunomodulation. The hepatic microenvironment and traditional systemic immunosuppression stress the vulnerable islets and contribute to the limited success of transplantation. Locally delivering extracellular matrix proteins and trophic factors can enhance transplantation at extrahepatic sites by promoting islet engraftment, revascularisation and long-term function while avoiding unintended systemic effects. Cell- and cytokine-based therapies for immune cell recruitment and reprogramming can inhibit local and systemic immune system activation that normally attacks transplanted islets. Combined with antigen-specific immunotherapies, states of operational tolerance may be achievable, reducing or eliminating the long-term pharmaceutical burden. Integration of these technologies to enhance engraftment and combat rejection may help to advance the therapeutic efficacy and availability of islet transplantation.
Collapse
|
406
|
Ye H, Huang G, Pei L, Zeng P, Luo X. Efficacy of sequential treatment protocol with highly purified urinary FSH and recombinant FSH for controlled ovarian stimulation. Fertil Steril 2011. [DOI: 10.1016/j.fertnstert.2011.07.975] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
407
|
Thomas JL, Vihtelic TS, denDekker AD, Willer G, Luo X, Murphy TR, Gregg RG, Hyde DR, Thummel R. The loss of vacuolar protein sorting 11 (vps11) causes retinal pathogenesis in a vertebrate model of syndromic albinism. Invest Ophthalmol Vis Sci 2011. [DOI: 10.1167/iovs.10-6795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
408
|
Skubitz KM, Francis P, Skubitz A, Luo X, Nilbert M. Heterogeneity of metastatic behavior among high-grade pleomorphic soft tissue sarcomas identified by gene expression analysis. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.10082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
409
|
Fujikawa-Yamamoto K, Miyagoshi M, Luo X, Yamagishi H. DNA-unstable decaploid mouse H1 (ES) cells established from DNA-stable pentaploid H1 (ES) cells polyploidized using demecolcine. Cell Prolif 2011; 44:111-9. [PMID: 21401752 DOI: 10.1111/j.1365-2184.2011.00734.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
OBJECTIVES DNA content of diploid H1 (ES) cells (2H1 cells) has been shown to be stable in long-term culture; however, tetraploid and octaploid H1 (ES) cells (4H1 and 8H1 cells, respectively) were DNA-unstable. Pentaploid H1 (ES) cells (5H1 cells) established recently have been found to be DNA-stable; how, then is cell DNA stability determined? To discuss ploidy stability, decaploid H1 (ES) cells (10H1 cells) were established from 5H1 cells and examined for DNA stability. MATERIALS AND METHODS 5H1 cells were polyploidized using demecolcine (DC) and 10H1 cells were obtained by one-cell cloning. RESULTS Number of chromosomes of 10H1 cells was 180 and durations of their G(1), S, and G(2)/M phases were 3, 7 and 6 h respectively. Volume of 10H1 cells was double that of 5H1 cells and morphology of 10H1 cells was flagstone-like in shape. 10H1 cells exhibited alkaline phosphatase activity and their DNA content decayed in 91 days of culture. 10H1 cells injected into mouse abdomen formed solid tumours that contained several kinds of differentiated cells with lower DNA content, suggesting that 10H1 cells were pluripotent and DNA-unstable. Loss of DNA stability was explained using a hypothesis concerning DNA structure of polyploid cells as DNA reconstructed through ploidy doubling was arranged in mirror symmetry in a new configuration. CONCLUSION In the pentaploid-decaploid transition of H1 cells, cell cycle parameters and pluripotency were retained, but morphology and DNA stability were altered.
Collapse
|
410
|
Guo L, Luo X, Zhao A, Huang H, Wei Z, Chen L, Qin S, Shao L, Xuan J, Feng G, Minghua C, Luan J, He L, Xing Q. A novel heterozygous nonsense mutation of keratin 5 in a chinese family with Dowling-Degos disease. J Eur Acad Dermatol Venereol 2011; 26:908-10. [DOI: 10.1111/j.1468-3083.2011.04115.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
411
|
Lee SM, Yang H, Tartar DM, Gao B, Luo X, Ye SQ, Zaghouani H, Fang D. Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes. Diabetologia 2011; 54:1136-46. [PMID: 21340626 PMCID: PMC4036531 DOI: 10.1007/s00125-011-2064-1] [Citation(s) in RCA: 105] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/15/2010] [Accepted: 12/23/2010] [Indexed: 12/15/2022]
Abstract
AIMS/HYPOTHESIS We recently found that activation of the type III histone deacetylase sirtuin 1 suppresses T cell immune responses. Here we sought to determine the therapeutic potential of the sirtuin 1 activator resveratrol in the treatment of diabetes in the NOD mouse model of type 1 diabetes and the mechanisms underlying such potential. METHODS NOD mice were fed or subcutaneously injected with resveratrol and evaluated for development of diabetes. Splenocytes from resveratrol-treated and control mice were analysed by gene array. The altered expression of inflammatory genes induced by resveratrol was validated and the role of changed gene expression in prevention of diabetes was determined. RESULTS Resveratrol administration potently prevented and treated type 1 diabetes in NOD mice. Gene array analysis indicated a dramatic decrease in expression of Ccr6, which encodes chemokine (C-C motif) receptor (CCR) 6, in the splenocytes from resveratrol-treated mice. CCR6 abundance on IL-17-producing cells and CD11b(+)F4/80(hi) macrophages was inhibited by resveratrol treatment. Interestingly, CCR6(+) IL-17-producing cells and CD11b(+)F4/80(hi) macrophages accumulated in the spleens and pancreatic lymph nodes, but their presence in the pancreas was reduced, suggesting that resveratrol blocks their migration from peripheral lymphoid organs to the pancreas. Indeed, the migration of splenocytes toward media containing chemokine (C-C motif) ligand 20 (CCL20) was impaired by resveratrol treatment. CCL20 peptides, which block CCR6 binding to CCL20, inhibited development of type 1 diabetes. CONCLUSIONS/INTERPRETATION Inhibition of CCR6-mediated migration of inflammatory cells by resveratrol may provide a powerful approach for treatment of type 1 diabetes and possibly of other inflammatory diseases.
Collapse
|
412
|
Aggarwal MM, Ahammed Z, Alakhverdyants AV, Alekseev I, Alford J, Anderson BD, Anson CD, Arkhipkin D, Averichev GS, Balewski J, Beavis DR, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Biritz B, Bland LC, Borowski W, Bouchet J, Braidot E, Brandin AV, Bridgeman A, Brovko SG, Bruna E, Bueltmann S, Bunzarov I, Burton TP, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Cebra D, Cendejas R, Cervantes MC, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Choi KE, Christie W, Chung P, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Dash S, Davila Leyva A, De Silva LC, Debbe RR, Dedovich TG, Derevschikov AA, Derradi de Souza R, Didenko L, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Dunlop JC, Dutta Mazumdar MR, Efimov LG, Elnimr M, Engelage J, Eppley G, Erazmus B, Estienne M, Eun L, Evdokimov O, Fatemi R, Fedorisin J, Fersch RG, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gangadharan DR, Ganti MS, Geromitsos A, Geurts F, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk O, Grosnick D, Guertin SM, Gupta A, Guryn W, Haag B, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heinz M, Heppelmann S, Hirsch A, Hjort E, Hoffmann GW, Hofman DJ, Huang B, Huang HZ, Humanic TJ, Huo L, Igo G, Jacobs P, Jacobs WW, Jena C, Jin F, Joseph J, Judd EG, Kabana S, Kang K, Kapitan J, Kauder K, Keane D, Kechechyan A, Kettler D, Kikola DP, Kiryluk J, Kisiel A, Kizka V, Klein SR, Knospe AG, Kocoloski A, Koetke DD, Kollegger T, Konzer J, Koralt I, Koroleva L, Korsch W, Kotchenda L, Kouchpil V, Kravtsov P, Krueger K, Krus M, Kumar L, Kurnadi P, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee CH, Lee JH, Leight W, LeVine MJ, Li C, Li L, Li N, Li W, Li X, Li X, Li Y, Li ZM, Lisa MA, Liu F, Liu H, Liu J, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Lukashov EV, Luo X, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Mangotra LK, Manweiler R, Margetis S, Markert C, Masui H, Matis HS, Matulenko YA, McDonald D, McShane TS, Meschanin A, Milner R, Minaev NG, Mioduszewski S, Mischke A, Mitrovski MK, Mohanty B, Mondal MM, Morozov B, Morozov DA, Munhoz MG, Naglis M, Nandi BK, Nayak TK, Netrakanti PK, Ng MJ, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Ohlson A, Okorokov V, Oldag EW, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Peitzmann T, Perkins C, Peryt W, Phatak SC, Pile P, Planinic M, Ploskon MA, Pluta J, Plyku D, Poljak N, Poskanzer AM, Potukuchi BVKS, Powell CB, Prindle D, Pruneau C, Pruthi NK, Pujahari PR, Putschke J, Qiu H, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Ruan L, Sakai S, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Sangaline E, Schambach J, Scharenberg RP, Schmah AM, Schmitz N, Schuster TR, Seele J, Seger J, Selyuzhenkov I, Seyboth P, Shahaliev E, Shao M, Sharma M, Shi SS, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Sorensen P, Spinka HM, Srivastava B, Stanislaus TDS, Staszak D, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Timoshenko S, Tlusty D, Tokarev M, Trainor TA, Tram VN, Trentalange S, Tribble RE, Tsai OD, Ullrich T, Underwood DG, Van Buren G, van Leeuwen M, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Vasiliev AN, Videbæk F, Viyogi YP, Vokal S, Voloshin SA, Wada M, Walker M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu YF, Xie W, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yepes P, Yip K, Yoo IK, Yue Q, Zawisza M, Zbroszczyk H, Zhan W, Zhang JB, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao J, Zhong C, Zhou W, Zhu X, Zhu YH, Zoulkarneev R, Zoulkarneeva Y. Measurement of the parity-violating longitudinal single-spin asymmetry for W± boson production in polarized proton-proton collisions at sqrt[s] = 500 GeV. PHYSICAL REVIEW LETTERS 2011; 106:062002. [PMID: 21405460 DOI: 10.1103/physrevlett.106.062002] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/03/2010] [Indexed: 05/30/2023]
Abstract
We report the first measurement of the parity-violating single-spin asymmetries for midrapidity decay positrons and electrons from W+ and W- boson production in longitudinally polarized proton-proton collisions at sqrt[s] = 500 GeV by the STAR experiment at RHIC. The measured asymmetries, A(L)(W+) = -0.27 ± 0.10(stat.) ± 0.02(syst.) ± 0.03(norm.) and A(L)(W-) = 0.14 ± 0.19(stat.) ± 0.02(syst.) ± 0.01(norm.), are consistent with theory predictions, which are large and of opposite sign. These predictions are based on polarized quark and antiquark distribution functions constrained by polarized deep-inelastic scattering measurements.
Collapse
|
413
|
Santos LF, Pereira T, Rodrigues B, Correia E, Moreira D, Vidinha J, Nunes L, Costa A, Machado J, Castedo S, Santos O, Luo X, Pan Z, Xiao J, Zhang J, Lu Y, Yang B, Wang Z, Ortega MC, Morejon AEG, Heo JY, Madras A, Barin E. Young Investigator Abstract Session. Europace 2011. [DOI: 10.1093/europace/euq488] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
414
|
Cryer B, Luo X, Assaf AR, Sands G, Mardekian J. Persistence with non-selective NSAIDs and celecoxib among patients with gastroesophageal reflux disease and osteoarthritis or rheumatoid arthritis. Curr Med Res Opin 2011; 27:295-302. [PMID: 21142617 DOI: 10.1185/03007995.2010.542056] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
OBJECTIVE Gastrointestinal (GI) symptoms are common in patients taking nonselective, nonsteroidal anti-inflammatory drugs (nsNSAIDs) and are often a reason for therapy discontinuation. In osteoarthritis (OA) and rheumatoid arthritis (RA) patients requiring pain control, selective COX-2 NSAID use is typically associated with less dyspepsia than is nsNSAID use. Little is known about NSAID tolerance in patients with gastroesophageal reflux disease (GERD). This study assessed nsNSAID and celecoxib prescription patterns, in particular persistence, in OA/RA patients with concomitant diagnosis of GERD. METHODS An observational study of GERD patients with a diagnosis of OA/RA using two separate databases, the IMS Lifelink Health Plan Claims Database (PharMetrics) and Market Scan Claims Database (Medstat) was conducted. In each database, parallel and separate analyses were performed in adult patients who had their first GERD diagnosis in 2006 and who were subsequently diagnosed with OA or RA in the same year. From this subset of patients, celecoxib-naïve and nsNSAID-naïve cohorts were identified and patients were selected. Patients with pre-existing GI conditions were excluded from the study. Persistence, measured as time to discontinuation, was evaluated by Kaplan-Meier survival curves and Cox proportional hazards models. Reasons for discontinuations were not available in these databases. RESULTS Fewer patients discontinued celecoxib as compared to nsNSAIDs during the 60 days of the first prescription and throughout the entire follow-up period. After adjusting for baseline characteristics, celecoxib patients still had significantly decreased risk of discontinuation as compared to nsNSAID patients (p < 0.0001). Replication of these observations in two separate, large patient databases increases the confidence in this study's conclusion. LIMITATIONS Limitations include those inherent to claims data analyses and retrospective review, e.g. these data do not provide clinical information related to reasons for medication discontinuation. CONCLUSION In patients with concomitant GERD and OA or RA who require anti-inflammatory treatment, significantly more patients treated with celecoxib were persistent with their treatment than were patients treated with nsNSAIDs.
Collapse
|
415
|
Wang S, Tang Y, Cui H, Zhao X, Luo X, Pan W, Huang X, Shen N. Let-7/miR-98 regulate Fas and Fas-mediated apoptosis. Genes Immun 2011; 12:149-54. [PMID: 21228813 DOI: 10.1038/gene.2010.53] [Citation(s) in RCA: 83] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Fas is ubiquitously expressed on a variety of cells and triggers apoptosis, which have critical roles in the immune system. MicroRNAs (miRNAs) have been recently identified as regulators that modulate target gene expression and are involved in diverse biological processes, such as cell proliferation and apoptosis. This study was undertaken to investigate the contribution of miRNA in the regulation of Fas expression and Fas-mediated apoptosis. Bioinformatics analysis indicated that Fas was a potential target of let-7/miR-98 family. Indeed ectopic expression of let-7/miR-98 reduced, whereas knockdown of endogenous let-7/miR-98 increased the expression of Fas at both mRNA and protein levels. Let-7/miR-98 was verified to target Fas 3' untranslated region directly by site-directed gene mutagenesis and reporter gene assay. More importantly, introduction of let-7/miR-98 could decrease the sensitivity to Fas-induced apoptosis. Furthermore, let-7/miR-98 expression was reduced in activation-induced cell death process, accompanied by increased expression of Fas. In conclusion, our study first demonstrated that let-7/miR-98 regulated Fas expression and the sensitivity of Fas-mediated apoptosis.
Collapse
|
416
|
Wei W, Luo X, Zheng L, Yu M, Jiang N, Xu XY, Yang ZR. Isolation of a Wild Morchella spp. Strain and the Effects of its Extract on Ethanol-Induced Gastric Mucosal Lesions in Rats. Z NATURFORSCH C 2011. [DOI: 10.5560/znc.2011.66c0055] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
417
|
Luo X, Day C. 3D Monte Carlo vacuum modeling of the neutral beam injection system of ITER. FUSION ENGINEERING AND DESIGN 2010. [DOI: 10.1016/j.fusengdes.2010.04.002] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
418
|
Koev ST, Dykstra PH, Luo X, Rubloff GW, Bentley WE, Payne GF, Ghodssi R. Chitosan: an integrative biomaterial for lab-on-a-chip devices. LAB ON A CHIP 2010; 10:3026-3042. [PMID: 20877781 DOI: 10.1039/c0lc00047g] [Citation(s) in RCA: 91] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
Chitosan is a naturally derived polymer with applications in a variety of industrial and biomedical fields. Recently, it has emerged as a promising material for biological functionalization of microelectromechanical systems (bioMEMS). Due to its unique chemical properties and film forming ability, chitosan serves as a matrix for the assembly of biomolecules, cells, nanoparticles, and other substances. The addition of these components to bioMEMS devices enables them to perform functions such as specific biorecognition, enzymatic catalysis, and controlled drug release. The chitosan film can be integrated in the device by several methods compatible with standard microfabrication technology, including solution casting, spin casting, electrodeposition, and nanoimprinting. This article surveys the usage of chitosan in bioMEMS to date. We discuss the common methods for fabrication, modification, and characterization of chitosan films, and we review a number of demonstrated chitosan-based microdevices. We also highlight the advantages of chitosan over some other functionalization materials for micro-scale devices.
Collapse
|
419
|
Aggarwal MM, Ahammed Z, Alakhverdyants AV, Alekseev I, Alford J, Anderson BD, Anson D, Arkhipkin D, Averichev GS, Balewski J, Barnby LS, Baumgart S, Beavis DR, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Biritz B, Bland LC, Bonner BE, Bouchet J, Braidot E, Brandin AV, Bridgeman A, Bruna E, Bueltmann S, Bunzarov I, Burton TP, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Catu O, Cebra D, Cendejas R, Cervantes MC, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Choi KE, Christie W, Chung P, Clarke RF, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Das D, Dash S, Davila Leyva A, De Silva LC, Debbe RR, Dedovich TG, Derevschikov AA, Derradi de Souza R, Didenko L, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Dunlop JC, Dutta Mazumdar MR, Efimov LG, Elhalhuli E, Elnimr M, Engelage J, Eppley G, Erazmus B, Estienne M, Eun L, Evdokimov O, Fachini P, Fatemi R, Fedorisin J, Fersch RG, Filip P, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gangadharan DR, Ganti MS, Garcia-Solis EJ, Geromitsos A, Geurts F, Ghazikhanian V, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk O, Grosnick D, Guertin SM, Gupta A, Guryn W, Haag B, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heinz M, Heppelmann S, Hirsch A, Hjort E, Hoffman AM, Hoffmann GW, Hofman DJ, Huang B, Huang HZ, Humanic TJ, Huo L, Igo G, Jacobs P, Jacobs WW, Jena C, Jin F, Jones CL, Jones PG, Joseph J, Judd EG, Kabana S, Kajimoto K, Kang K, Kapitan J, Kauder K, Keane D, Kechechyan A, Kettler D, Kikola DP, Kiryluk J, Kisiel A, Kizka V, Klein SR, Knospe AG, Kocoloski A, Koetke DD, Kollegger T, Konzer J, Koralt I, Koroleva L, Korsch W, Kotchenda L, Kouchpil V, Kravtsov P, Krueger K, Krus M, Kumar L, Kurnadi P, Lamont MAC, Landgraf JM, Lapointe S, Lauret J, Lebedev A, Lednicky R, Lee CH, Lee JH, Leight W, Levine MJ, Li C, Li L, Li N, Li W, Li X, Li X, Li Y, Li ZM, Lin G, Lin XY, Lindenbaum SJ, Lisa MA, Liu F, Liu H, Liu J, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Lukashov EV, Luo X, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Mangotra LK, Manweiler R, Margetis S, Markert C, Masui H, Matis HS, Matulenko YA, McDonald D, McShane TS, Meschanin A, Milner R, Minaev NG, Mioduszewski S, Mischke A, Mitrovski MK, Mohanty B, Mondal MM, Morozov B, Morozov DA, Munhoz MG, Nandi BK, Nattrass C, Nayak TK, Nelson JM, Netrakanti PK, Ng MJ, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Okorokov V, Oldag EW, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Phatak SC, Pile P, Planinic M, Ploskon MA, Pluta J, Plyku D, Poljak N, Poskanzer AM, Potukuchi BVKS, Powell CB, Prindle D, Pruneau C, Pruthi NK, Pujahari PR, Putschke J, Qiu H, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Roy C, Ruan L, Sahoo R, Sakai S, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Sangaline E, Schambach J, Scharenberg RP, Schmitz N, Schuster TR, Seele J, Seger J, Selyuzhenkov I, Seyboth P, Shahaliev E, Shao M, Sharma M, Shi SS, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stanislaus TDS, Staszak D, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Timoshenko S, Tlusty D, Tokarev M, Trainor TA, Tram VN, Trentalange S, Tribble RE, Tsai OD, Ulery J, Ullrich T, Underwood DG, Van Buren G, van Leeuwen M, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Vasiliev AN, Videbaek F, Viyogi YP, Vokal S, Voloshin SA, Wada M, Walker M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu YF, Xie W, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yepes P, Yip K, Yoo IK, Yue Q, Zawisza M, Zbroszczyk H, Zhan W, Zhang JB, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao J, Zhong C, Zhou J, Zhou W, Zhu X, Zhu YH, Zoulkarneev R, Zoulkarneeva Y. Measurement of the bottom quark contribution to nonphotonic electron production in p + p collisions at √s=200 GeV. PHYSICAL REVIEW LETTERS 2010; 105:202301. [PMID: 21231222 DOI: 10.1103/physrevlett.105.202301] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/07/2010] [Indexed: 05/30/2023]
Abstract
The contribution of B meson decays to nonphotonic electrons, which are mainly produced by the semileptonic decays of heavy-flavor mesons, in p + p collisions at √s=200 GeV has been measured using azimuthal correlations between nonphotonic electrons and hadrons. The extracted B decay contribution is approximately 50% at a transverse momentum of pT≥5 GeV/c. These measurements constrain the nuclear modification factor for electrons from B and D meson decays. The result indicates that B meson production in heavy ion collisions is also suppressed at high pT.
Collapse
|
420
|
Sperduto P, Xu Z, Sneed P, Luo X, Roberge D, Bhatt A, Jensen A, Shih H, Kirkpatrick J, Gaspar L. The Graded Prognostic Assessment for Women with Brain Metastases from Breast Cancer (GPA-Breast): A Diagnosis-specific Prognostic Index. Int J Radiat Oncol Biol Phys 2010. [DOI: 10.1016/j.ijrobp.2010.07.057] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
421
|
Yang Y, Lin X, Fu W, Luo X, Kang K. An approach to the correlation between vitiligo and autoimmune thyroiditis in Chinese children. Clin Exp Dermatol 2010; 35:706-10. [PMID: 19874359 DOI: 10.1111/j.1365-2230.2009.03671.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
BACKGROUND Vitiligo is a common skin depigmenting disease, which is thought to have, at least partly, an autoimmune aetiology. AIM To explore the correlation between paediatric vitiligo and other associated diseases, with an emphasis on autoimmune thyroiditis (AT). METHODS In total, 363 paediatric patients (198 boys, 165 girls) with vitiligo and 93 healthy children (55 boys, 38 girls) were screened for autoimmune thyroiditis. The two groups were matched for age and gender. Children with vitiligo were split into two groups according to type (segmental and nonsegmental vitiligo). Demographic data, clinical features and examinations were recorded using questionnaires. Thyroid function tests including free triiodothyronine, free thyroxine and thyroid-stimulating hormone were performed. Anti-thyroid peroxidase antibody) and anti-thyroglobulin antibody levels were assessed as well. Other associated diseases were also monitored in this study. RESULTS Of the 363 patients, 43 (11.8%) had abnormal levels of studied thyroid parameters, compared with 4 of the 93 controls (4.3%); the difference was significant (P = 0.04). The alterations of thyroid parameters and the incidence of AT in patients with nonsegmental vitiligo were both significantly different (P < 0.05, P = 0.04) relative to the segmental vitiligo group. Of the 363 patients, 67 (18.5%) had other associated diseases. There were no differences in the rates of other associated diseases between patients with segmental vitiligo and those with nonsegmental vitiligo (P > 0.05). CONCLUSIONS A significant incidence of thyroid dysfunction was found in paediatric patients with nonsegmental vitiligo. As vitiligo usually appears before the development of the thyroid disease, it may be advantageous to screen thyroid functions and antibody levels in all paediatric patients with vitiligo, especially those with nonsegmental vitiligo.
Collapse
|
422
|
Pothoven KL, Kheradmand T, Yang Q, Houlihan JL, Zhang H, DeGutes M, Miller SD, Luo X. Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation. Am J Transplant 2010; 10:1774-84. [PMID: 20626386 PMCID: PMC3995630 DOI: 10.1111/j.1600-6143.2010.03199.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Dendritic cells (DCs) conditioned with the mammalian target of rapamycin (mTOR) inhibitor rapamycin have been previously shown to expand naturally existing regulatory T cells (nTregs). This work addresses whether rapamycin-conditioned donor DCs could effectively induce CD4(+)CD25(+)Foxp3(+) Tregs (iTregs) in cell cultures with alloantigen specificities, and whether such in vitro-differentiated CD4(+)CD25(+)Foxp3(+) iTregs could effectively control acute rejection in allogeneic islet transplantation. We found that donor BALB/c bone marrow-derived DCs (BMDCs) pharmacologically modified by the mTOR inhibitor rapamycin had significantly enhanced ability to induce CD4(+)CD25(+)Foxp3(+) iTregs of recipient origin (C57BL/6 (B6)) in vitro under Treg driving conditions compared to unmodified BMDCs. These in vitro-induced CD4(+)CD25(+)Foxp3(+) iTregs exerted donor-specific suppression in vitro, and prolonged allogeneic islet graft survival in vivo in RAG(-/-) hosts upon coadoptive transfer with T-effector cells. The CD4(+)CD25(+)Foxp3(+) iTregs expanded and preferentially maintained Foxp3 expression in the graft draining lymph nodes. Finally, the CD4(+)CD25(+)Foxp3(+) iTregs were further able to induce endogenous naïve T cells to convert to CD4(+)CD25(+)Foxp3(+) T cells. We conclude that rapamycin-conditioned donor BMDCs can be exploited for efficient in vitro differentiation of donor antigen-specific CD4(+)CD25(+)Foxp3(+) iTregs. Such in vitro-generated donor-specific CD4(+)CD25(+)Foxp3(+) iTregs are able to effectively control allogeneic islet graft rejection.
Collapse
|
423
|
Zhang J, Wang P, Huang YB, Li J, Zhu J, Luo X, Shi HM, Li Y. Plasma Cathepsin L and Its Related Pro/Antiangiogenic Factors Play Useful Roles in Predicting Rich Coronary Collaterals in Patients with Coronary Heart Disease. J Int Med Res 2010; 38:1389-403. [PMID: 20926012 DOI: 10.1177/147323001003800421] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023] Open
Abstract
Cathepsin L enhances angiogenesis by increasing extracellular matrix degradation and remodelling. This study investigated whether plasma cathepsin L could be used as a biomarker to predict collateral formation in patients with coronary heart disease (CHD). Patients with CHD ( n = 218; aged 67 ± 11 years) underwent coronary angiography and were categorized as having either ‘poor’ or ‘rich’ collaterals. Plasma cathepsin L, the proangiogenic placenta growth factor (PLGF) and the antiangiogenic factors, cystatin C and endostatin, were measured. Elevated cathepsin L and PLGF levels were independently and significantly associated with enhanced collateral formation in patients with CHD; subgroup analyses also showed a significant correlation in patients with diabetes and acute coronary syndrome. Plasma endostatin and cystatin C levels were not significantly correlated with coronary collateral formation. Plasma cathepsin L and PLGF, acting as important modulators of angiogenesis, could be used as biomarkers to predict coronary collateral formation in patients with CHD.
Collapse
|
424
|
Luo X, Gleisner R, Tian S, Negron J, Zhu W, Horn E, Pan XJ, Zhu JY. Evaluation of Mountain Beetle-Infested Lodgepole Pine for Cellulosic Ethanol Production by Sulfite Pretreatment to Overcome Recalcitrance of Lignocellulose. Ind Eng Chem Res 2010. [DOI: 10.1021/ie1003202] [Citation(s) in RCA: 100] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
425
|
Aggarwal MM, Ahammed Z, Alakhverdyants AV, Alekseev I, Alford J, Anderson BD, Arkhipkin D, Averichev GS, Balewski J, Barnby LS, Baumgart S, Beavis DR, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Biritz B, Bland LC, Bonner BE, Bouchet J, Braidot E, Brandin AV, Bridgeman A, Bruna E, Bueltmann S, Bunzarov I, Burton TP, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Catu O, Cebra D, Cendejas R, Cervantes MC, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Choi KE, Christie W, Chung P, Clarke RF, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Das D, Dash S, Davila Leyva A, De Silva LC, Debbe RR, Dedovich TG, Derevschikov AA, Derradi de Souza R, Didenko L, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Dunlop JC, Dutta Mazumdar MR, Efimov LG, Elhalhuli E, Elnimr M, Engelage J, Eppley G, Erazmus B, Estienne M, Eun L, Evdokimov O, Fachini P, Fatemi R, Fedorisin J, Fersch RG, Filip P, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gangadharan DR, Ganti MS, Garcia-Solis EJ, Geromitsos A, Geurts F, Ghazikhanian V, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk O, Grosnick D, Guertin SM, Gupta A, Gupta N, Guryn W, Haag B, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heinz M, Heppelmann S, Hirsch A, Hjort E, Hoffman AM, Hoffmann GW, Hofman DJ, Huang B, Huang HZ, Humanic TJ, Huo L, Igo G, Jacobs P, Jacobs WW, Jena C, Jin F, Jones CL, Jones PG, Joseph J, Judd EG, Kabana S, Kajimoto K, Kang K, Kapitan J, Kauder K, Keane D, Kechechyan A, Kettler D, Kikola DP, Kiryluk J, Kisiel A, Klein SR, Knospe AG, Kocoloski A, Koetke DD, Kollegger T, Konzer J, Koralt I, Koroleva L, Korsch W, Kotchenda L, Kouchpil V, Kravtsov P, Krueger K, Krus M, Kumar L, Kurnadi P, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee CH, Lee JH, Leight W, LeVine MJ, Li C, Li L, Li N, Li W, Li X, Li X, Li Y, Li ZM, Lin G, Lindenbaum SJ, Lisa MA, Liu F, Liu H, Liu J, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Lukashov EV, Luo X, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Mangotra LK, Manweiler R, Margetis S, Markert C, Masui H, Matis HS, Matulenko YA, McDonald D, McShane TS, Meschanin A, Milner R, Minaev NG, Mioduszewski S, Mischke A, Mitrovski MK, Mohanty B, Mondal MM, Morozov B, Morozov DA, Munhoz MG, Nandi BK, Nattrass C, Nayak TK, Nelson JM, Netrakanti PK, Ng MJ, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Okorokov V, Oldag EW, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Phatak SC, Pile P, Planinic M, Ploskon MA, Pluta J, Plyku D, Poljak N, Poskanzer AM, Potukuchi BVKS, Powell CB, Prindle D, Pruneau C, Pruthi NK, Pujahari PR, Putschke J, Qiu H, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Roy C, Ruan L, Sahoo R, Sakai S, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Sangaline E, Schambach J, Scharenberg RP, Schmitz N, Schuster TR, Seele J, Seger J, Selyuzhenkov I, Seyboth P, Shahaliev E, Shao M, Sharma M, Shi SS, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stanislaus TDS, Staszak D, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Timoshenko S, Tlusty D, Tokarev M, Tram VN, Trentalange S, Tribble RE, Tsai OD, Ulery J, Ullrich T, Underwood DG, Van Buren G, van Leeuwen M, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Vasiliev AN, Videbaek F, Viyogi YP, Vokal S, Voloshin SA, Wada M, Walker M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu YF, Xie W, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yepes P, Yip K, Yoo IK, Yue Q, Zawisza M, Zbroszczyk H, Zhan W, Zhang JB, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao J, Zhong C, Zhou J, Zhou W, Zhu X, Zhu YH, Zoulkarneev R, Zoulkarneeva Y. Higher moments of net proton multiplicity distributions at RHIC. PHYSICAL REVIEW LETTERS 2010; 105:022302. [PMID: 20867702 DOI: 10.1103/physrevlett.105.022302] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/28/2010] [Indexed: 05/29/2023]
Abstract
We report the first measurements of the kurtosis (κ), skewness (S), and variance (σ2) of net-proton multiplicity (Np-Np) distributions at midrapidity for Au+Au collisions at square root of s(NN)=19.6, 62.4, and 200 GeV corresponding to baryon chemical potentials (μB) between 200 and 20 MeV. Our measurements of the products κσ2 and Sσ, which can be related to theoretical calculations sensitive to baryon number susceptibilities and long-range correlations, are constant as functions of collision centrality. We compare these products with results from lattice QCD and various models without a critical point and study the square root of s(NN) dependence of κσ2. From the measurements at the three beam energies, we find no evidence for a critical point in the QCD phase diagram for μB below 200 MeV.
Collapse
|